A novel E3 ubiquitin ligase TRAC-1 positively regulates T cell activation

Journal of Immunology

Volumn 174, Issue 9, 2005, Pages 5288-5297

  Zhao, Haoran ^a   Li, Connie C ^a,b   Pardo, Jorge ^a,c   Chu, Peter C ^a   Liao, Charlene X ^a,d   Huang, Jianing ^a   Dong, John G ^a   Zhou, Xiulan ^a   Huang, Qi ^a   Huang, Betty ^a   Bennett, Mark K ^a,e   Molineaux, Susan M ^a,e   Lu, Henry ^a   Daniel Issakani, Sarkiz ^a   Payan, Donald G ^a   Masuda, Esteban S ^a  

^a RIGEL PHARMACEUTICALS INC   (United States)

^b EXELIXIS INC   (United States)

^c NAVAL MEDICAL RESEARCH CENTER   (United States)

^d GENENTECH INC   (United States)

^e Proteolix Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE TRAC 1; UNCLASSIFIED DRUG; ZINC;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LYMPHOID TISSUE; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

EID: 20944434221     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.9.5288     Document Type: Article

References (52)

1. Qian, D., and A. Weiss. 1997. T cell antigen receptor signal transduction. Curr. Opin. Cell Biol. 9:205.
2. Singer, A. L., and G. A. Koretzky. 2002. Control of T cell function by positive and negative regulators. Science 296:1639.
3. Cenciarelli, C., D. Hou, K. C. Hsu, B. L. Rellahan, D. L. Wiest, H. T. Smith, V. A. Fried, and A. M. Weissman. 1992. Activation-induced ubiquitination of the T cell antigen receptor. Science 257:795.
4. Fang, D., H. Y. Wang, N. Fang, Y. Altman, C. Elly, and Y. C. Liu. 2001. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells. J. Biol. Chem. 276:4872.
5. Wang, H. Y., Y. Altman, D. Fang, C. Elly, Y. Dai, Y. Shao, and Y. C. Liu. 2001. Cbl promotes ubiquitination of the T cell receptor zeta through an adaptor function of Zap-70. J. Biol. Chem. 276:26004.
6. Fang, D., C. Elly, B. Gao, N. Fang, Y. Altman, C. Joazeiro, T. Hunter, N. Copeland, N. Jenkins, and Y. C. Liu. 2002. Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. Nat. Immunol. 3:281.
7. Hershko, A., and A. Cicchanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425.
8. Kishino, T., M. Lalande, and J. Wagstaff. 1997. UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 15:70.
9. Iwai, K., K. Yamanaka, T. Kamura, N. Minato, R. C. Conaway, J. W. Conaway, R. D. Klausner, and A. Pause. 1999. Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc. Natl. Acad. Sci. USA 96:12436.
10. Giasson, B. I., and V. M. Lee. 2001. Parkin and the molecular pathways of Parkinson's disease. Neuron 31:885.
11. Ruffner, H., C. A. Joazeiro, D. Hemmati, T. Hunter, and I. M. Verma. 2001. Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc. Natl. Acad. Sci. USA 98:5134.
12. Hochstrasser, M. 1996. Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 30:405.
13. Huang, L., E. Kinnucan, G. Wang, S. Beaudenon, P. M. Howley, J. M. Huibregtse, and N. P. Pavletich. 1999. Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science 286:1321.
14. Zheng, N., P. Wang, P. D. Jeffrey, and N. P. Pavletich. 2000. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102:533.
15. Joazeiro, C. A., and A. M. Weissman. 2000. RING finger proteins: mediators of ubiquitin ligase activity. Cell 102:549.
16. Freemont, P. S. 2000. RING for destruction? Curr. Biol. 10:R84.
17. Huibregtse, J. M., M. Scheffner, S. Beaudenon, and P. M. Howley. 1995. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. USA 92:2563.
18. Lu, Z., S. Xu, C. Joazeiro, M. H. Cobb, and T. Hunter. 2002. The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2. Mol. Cell 9:945.
19. Coscoy, L., D. J. Sanchez, and D. Ganem. 2001. A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. J. Cell Biol. 155:1265.
20. Hatakeyama, S., M. Yada, M. Matsumoto, N. Ishida, and K. I. Nakayama. 2001. U box proteins as a new family of ubiquitin-protein ligases. J. Biol. Chem. 276:33111.
21. Deng, L., C. Wang, E. Spencer, L. Yang, A. Braun, J. You, C. Slaughter, C. Pickart, and Z. J. Chen. 2000. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103:351.
22. Kaiser, P., K. Flick, C. Wittenberg, and S. I. Reed. 2000. Regulation of transcription by ubiquitination without proteolysis: Cdc34/SCF(Met30)-mediated inactivation of the transcription factor Met4. Cell 102:303.
23. Langdon, W. Y., C. D. Hyland, R. J. Grumont, and H. C. Morse III. 1989. The c-cbl proto-oncogene is preferentially expressed in thymus and testis tissue and encodes a nuclear protein. J. Virol. 63:5420.
24. Thien, C. B., and W. Y. Langdon. 1998. c-Cbl: a regulator of T cell receptor-mediated signalling. Immunol. Cell Biol. 76:473.
25. Joazeiro, C. A., S. S. Wing, H. Huang, J. D. Leverson, T. Hunter, and Y. C. Liu. 1999. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286:309.
26. Krawczyk, C., and J. M. Penninger. 2001. Molecular controls of antigen receptor clustering and autoimmunity. Trends Cell Biol. 11:212.
27. Naramura, M., H. K. Kole, R. J. Hu, and H. Gu. 1998. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc. Natl. Acad. Sci. USA 95:15547.
28. Murphy, M. A., R. G. Schnall, D. J. Venter, L. Barnett, I. Bertoncello, C. B. Thien, W. Y. Langdon, and D. D. Bowtell. 1998. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol. Cell. Biol. 18:4872.
29. Chiang, Y. J., H. K. Kole, K. Brown, M. Naramura, S. Fukuhara, R. J. Hu, I. K. Jang, J. S. Gutkind, E. Shevach, and H. Gu. 2000. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403:216.
30. Bachmaier, K., C. Krawczyk, I. Kozieradzki, Y. Y. Kong, T. Sasaki, A. Oliveira-dos-Santos, S. Mariathasan, D. Bouchard, A. Wakeham, A. Itie, et al. 2000. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403:211.
31. Jeon, M. S., A. Atfield, K. Venuprasad, C. Krawczyk, R. Sarao, C. Elly, C. Yang, S. Arya, K. Bachmaier, L. Su, et al. 2004. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21:167.
32. Liu, Y. C., and H. Gu. 2002. Cbl and Cbl-b in T-cell regulation. Trends Immunol. 23:140.
33. Magnifico, A., S. Ettenberg, C. Yang, J. Mariano, S. Tiwari, S. Fang, S. Lipkowitz, and A. M. Weissman. 2003. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J. Biol. Chem. 278:43169.
34. Perry, W. L., C. M. Hustad, D. A. Swing, T. N. O'Sullivan, N. A. Jenkins, and N. G. Copeland. 1998. The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice. Nat. Genet. 18:143.
35. Heissmeyer, V., F. Macian, S. H. Im, R. Varma, S. Feske, K. Venuprasad, H. Gu, Y. C. Liu, M. L. Dustin, and A. Rao. 2004. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat. Immunol. 5:255.
36. + T cells. Immunity 18:535.
37. Soares, L., C. Seroogy, H. Skrenta, N. Anandasabapathy, P. Lovelace, C. D. Chung, E. Engleman, and C. G. Fathman. 2004. Two isoforms of otubain 1 regulate T cell anergy via GRAIL. Nat. Immunol. 5:45.
38. Chu, P., J. Pardo, H. Zhao, C. C. Li, E. Pali, M. M. Shen, K. Qu, S. X. Yu, B. C. Huang, P. Yu, et al. 2003. Systematic identification of regulatory proteins critical for T-cell activation. J. Biol. 2:21.
39. Swift, S. E., J. B. Loren, P. Achacoso, and G. P. Nolan. 1999. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. In: Current Protocols in Immunology. D. H. K. A. M. Congan, S. E. M. Marguiies, and W. Strober, eds. Wiley, New York, pp. 10.17.14-10.17.29.
40. Holland, S. J., X. C. Liao, M. K. Mendenhall, X. Zhou, J. Pardo, P. Chu, C. Spencer, A. Fu, N. Sheng, P. Yu, et al. 2001. Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signaling. J. Exp. Med. 194:1263.
41. Huang, J. H. Q., X. Zhou, M. M. Shen, A. Yen, S. X. Yu, G. Dong, K. Qu, P. Huang, E. M. Andersen, S. Daniel-Issakani, et al. 2004. The poxvirus p28 virulence factor is an E3 ubiquitin ligase. J. Biol. Chem. 279:54110.
42. Nuber, U., S. Schwarz, P. Kaiser, R. Schneider, and M. Scheffner. 1996. Cloning of human ubiquitin-conjugating enzymes UbcH6 and UbcH7 (E2-F1) and characterization of their interaction with E6-AP and RSP5. J. Biol. Chem. 271:2795.
43. Kumar, S., W. H. Kao, and P. M. Howley. 1997. Physical interaction between specific E2 and Hect E3 enzymes determines functional cooperativity. J. Biol. Chem. 272:13548.
44. Shi, C. S., and J. H. Kehrl. 2003. Tumor necrosis factor (TNF)-induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (TRAF2). J. Biol. Chem. 278:15429.
45. Xia, Y., G. M. Pao, H. W. Chen, I. M. Verma, and T. Hunter. 2003. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein. J. Biol. Chem. 278:5255.
46. Hoege, C., B. Pfander, G. L. Moldovan, G. Pyrowolakis, and S. Jentsch. 2002. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419:135.
47. Bothos, J., M. K. Summers, M. Venere, D. M. Scolnick, and T. D. Halazonetis. 2003. The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form Lys63-linked polyubiquitin chains. Oncogene 22:7101.
48. Chen, A., K. Wu, S. Y. Fuchs, P. Tan, C. Gomez, and Z. Q. Pan. 2000. The conserved RING-H2 finger of ROC1 is required for ubiquitin ligation. J. Biol. Chem. 275:15432.
49. Isakov, N., and A. Altman. 2002. Protein kinase Cθ in T cell activation. Annu. Rev. Immunol. 20:761.
50. Arendt, C. W., B. Albrecht, T. J. Soos, and D. R. Littman. 2002. Protein kinase C-θ: signaling from the center of the T-cell synapse. Curr. Opin. Immunol. 14:323.
51. Wong, B. R., F. Parlati, K. Qu, S. Demo, T. Pray, J. Huang, D. G. Payan, and M. K. Bennett. 2003. Drug discovery in the ubiquitin regulatory pathway. Drug Discovery Today 8:746.
52. Pray, T. R., F. Parlati, J. Huang, B. R. Wong, D. G. Payan, M. K. Bennett, S. D. Issakani, S. Molineaux, and S. D. Demo. 2002. Cell cycle regulatory E3 ubiquitin ligases as anticancer targets. Drug Resist Update 5:249.